Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip to main content
During 1999–2019, age-adjusted rates of U.S. drug-involved overdose deaths more than tripled from 6.1 to 21.6 per 100,000 (1), and suicide rates (driven primarily by firearm suicide) increased 35.2% from 10.5 to 13.9 per 100,000 (2). However, no existing studies examined differences in trends in intentional overdose deaths by age, race/ethnicity, and sex, compared with firearm deaths by suicide (24). Furthermore, variations of intentional overdose deaths by month and day of the week are unknown. Nevertheless, knowing these can help inform prevention and intervention efforts. Thus, we examined 1) What are differences in national trends in intentional overdose deaths by age, race/ethnicity, and sex, compared with firearm deaths by suicide? and 2) What are variations of U.S. intentional overdose deaths by month and day of the week and by sex?

Method

Data were analyzed using the 2001–2019 National Vital Statistics System’s multiple cause-of-death mortality files. Intentional drug overdose deaths were those assigned an underlying cause of death with ICD-10, X60–X64; firearm deaths by suicide were X72–X74. Age-adjusted intentional overdose death rates were stratified by age, race/ethnicity, and sex. Joinpoint Regression Program (version 4.8.01) was used to test for significant changes in nonlinear trends using permutation tests.
To compare intentional overdose deaths by month, this study accounted for variations in the number of days by month and year (e.g., 29 days in February in a leap year) by examining adjusted mean number of intentional overdose deaths as the mean number of overdose deaths per day for a given month during 2001–2019 times 30 days. Death data were merged with average U.S. daylength by month and year. Mean numbers of intentional overdose deaths during 2001–2019 by day of the week were also assessed. Using SAS 9.4, Poisson regressions were applied in these analyses. A two-sided p value <0.05 was considered statistically significant.

Results

Although age-adjusted rates of intentional overdose deaths declined from 2012 to 2019 among men and from 2015 to 2019 among women (each p<0.001; see Table 1 in online supplement), rates trended upward among 15–24-year-old men from 2015 to 2019 (p=0.012), 15–24-year-old women from 2014 to 2019 (p<0.001), non-Hispanic Black women from 2013–2019 (p=0.015), and 75–84-year-old men and women from 2001 to 2019 (both p<0.001). Across groups by age and sex, rates were consistently highest among women aged 45–64 during 2001–2019 and were 41% higher than among men aged 45–64 in 2019 (p≤0.001).
By contrast, age-adjusted rates for suicides by firearm increased among men and women from 2006 to 2019 (each p<0.001; see Table 2 in online supplement), and rates did not trend downward in any subgroups in recent years. In 2019, rates were over 10 times higher than by intentional overdose for men overall and most subgroups but were only slightly higher than by intentional overdose among women overall (1.2 times higher), non-Hispanic white women, and women aged 15–44 (each p<0.001).
Adjusted mean number of intentional overdose deaths was higher in April-through-August for women and in March-through-August and January for men and was lowest in December for both sexes (p<0.05) (see Table 3 in online supplement). Long daylengths are in May-through-August, intermediate daylengths are in March-April and September-October, and short daylengths are in November-through-February (part a of Figure 1). We found intentional overdose deaths had a positive linear relationship with daylength for both sexes (incident risk ratio=1.020; p<0.001) (part b of Figure 1). For both sexes, intentional overdose deaths were lowest on Saturdays (similar to Sundays for men and Fridays for women) (p<0.05) (supplemental table 3 and part c of Figure 1) and highest on Mondays (p<0.05).
FIGURE 1. Intentional overdose deaths as a function of day and daylength
Data files: the 2001–2019 Multiple Cause-of-Death data from the National Vital Statistics System. The mean number of intentional drug overdose deaths on Saturdays was lower than Mondays through Thursdays for both sexes, was also lower than Fridays for men, and was lower than Sundays for women as well (p<0.05). It was higher on Mondays than all other days of the week for both sexes (p<0.05). See Table 3 in the online supplement for details.

Discussion

We observed recent upward trends in intentional overdose deaths in 15–24-year-olds for both sexes, which stand in contrast to recent downward trends for the overall male and female populations. These findings are consistent with increases in suicidal ideation, plan, and attempt in young people (5, 6) and highlight the urgent need for interventions to prevent suicides, including from intentional overdoses.
Researchers have reported that suicide behavior with opioid consumption follows a seasonal pattern that changes with latitude (7). Our study found a positive linear relationship between daylength, which varies by latitude, and intentional overdose deaths for both sexes. Interestingly, a brain-imaging study reported that daylength was associated with mu opioid receptor (MOR) availability that might underlie seasonal variations in mood and social behaviors (8). Another study showing altered MOR expression in postmortem brains of decedents by suicide further supports their relevance (9). MORs are the main targets of opioid drugs, which are the most frequent substances identified in intentional overdose deaths (3, 10). Taken together, these findings may help explain the peak intentional overdose deaths in Spring-through-Summer (encompassing long daylengths in May-through-August) that we observed for both sexes. Our results are also consistent with other findings of increased suicide behavior in the Spring and Summer months (11).
Importantly, social and cultural factors are likely to contribute to the lower intentional overdose deaths observed in December, which was also the month with the lowest suicide rate reported by an Austrian study (12). Social interactions and collective optimism during the holiday season might exert protective effects against suicidality.
Similarly, the lower intentional drug overdose deaths on Saturdays, could reflect protective effects of social interactions. Higher intentional overdoses on Mondays was also reported for intentional overdose deaths from England and Wales (13) and for suicides in England (14), suggesting effects attributed to beginning the routine transition from the weekend to the work week.
This study has limitations. Classifications of intentionality of drug overdose deaths may be inaccurate, and intentional overdose deaths may be underreported due to individual/system-level factors (15). In 2019, 5% of overdose deaths had undetermined intent (1), which may affect patterns of intentional overdose deaths. Improving classifications of overdose deaths is needed. These trends might have also changed during the COVID-19 pandemic as provisional mortality data indicate decreases in deaths from suicides (16), yet an approximately 30% increase in overall overdose deaths (17). Thus, further evaluations are needed.

Conclusions

Although intentional overdose death rates decreased during 2012–2019 in men and 2015–2019 in women, we identified recent upward trends among 15–24-year-olds (both sexes), 75–84-year-olds (both sexes), and non-Hispanic Black women. Our findings indicate consistently higher rates of intentional overdose deaths among women (highest among 45–64-year-olds) than men. Preventive interventions are especially needed to target these groups. We also observed peak intentional overdose deaths in Spring-through-Summer and on Mondays and lower rates in December and on Saturdays for both sexes. These monthly patterns and day of the week variabilities for intentional overdose deaths may be driven by socially established routines, daylength, and overlapping factors, which may inform related prevention and intervention efforts.

Footnotes

Sponsored by the National Institute on Drug Abuse of the National Institutes of Health. The sponsor supported the authors who were responsible for preparation, review, and approval of the manuscript and the decision to submit the manuscript for publication. The sponsor had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The sponsor reviewed and approved the manuscript.
The findings and conclusions of this study are those of the authors and do not necessarily reflect the views of the National Institute on Drug Abuse of the National Institutes of Health and the U.S. Department of Health and Human Services.

Supplementary Material

File (appi.ajp.2021.21060604.ds001.pdf)

References

1.
Hedegaard H, Miniño AM, Warner M: Drug overdose deaths in the United States, 1999–2019. NCHS Data Brief, no 394. Hyattsville, MD, National Center for Health Statistics, 2020
2.
Hedegaard H, Curtin SC, Warner M: Suicide Mortality in the United States, 1999-2019. NCHS Data Brief, no 398. Hyattsville, MD, National Center for Health Statistics, 2021
3.
Hempstead K, Phillips J: Divergence in recent trends in deaths from intentional and unintentional poisoning. Health Aff (Millwood) 2019; 38:29–35
4.
VanHouten JP, Rudd RA, Ballesteros MF, et al: Drug overdose deaths among women aged 30-64 years-United States, 1999-2017. MMWR Morb Mortal Wkly Rep 2019; 68:1–5
5.
Han B, Compton WM, Einstein EB, et al: Associations of suicidality trends with cannabis use as a function of sex and depression status. JAMA Netw Open 2021; 4:e2113025
6.
Han B: Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2020
7.
Davis JM, Searles VB, Severtson SG, et al: Seasonal variation in suicidal behavior with prescription opioid medication. J Affect Disord 2014; 158:30–36
8.
Sun L, Tang J, Liljenbäck H, et al: Seasonal variation in the brain μ-opioid receptor availability. J Neurosci 2021; 41:1265–1273
9.
Lutz PE, Almeida D, Filliol D, et al: Increased functional coupling of the mu opioid receptor in the anterior insula of depressed individuals. Neuropsychopharmacology 2021; 46:920–927
10.
Miller TR, Swedler DI, Lawrence BA, et al: Incidence and lethality of suicidal overdoses by drug class. JAMA Netw Open 2020; 3:e200607
11.
Woo JM, Okusaga O, Postolache TT: Seasonality of suicidal behavior. Int J Environ Res Public Health 2012; 9:531–547
12.
Plöderl M, Fartacek C, Kunrath S, et al: Nothing like Christmas--suicides during Christmas and other holidays in Austria. Eur J Public Health 2015; 25:410–413
13.
Johnson H, Brock A, Griffiths C, et al: Mortality from suicide and drug-related poisoning by day of the week in England and Wales, 1993-2002. Health Stat Q 2005; 27:13–16
14.
Cavanagh B, Ibrahim S, Roscoe A, et al: The timing of general population and patient suicide in England, 1997-2012. J Affect Disord 2016; 197:175–181
15.
Stone DM, Holland KM, Bartholow B, et al: Deciphering suicide and other manners of death associated with drug intoxication: A Centers for Disease Control and Prevention consultation meeting summary. Am J Public Health 2017; 107:1233–1239
16.
Ahmad FB, Anderson RN: The leading causes of death in the US for 2020. JAMA 2021; 325:1829–1830
17.
Centers for Disease Control and Prevention: Provisional Drug Overdose Death Counts. 12 month-ending provisional number of drug overdose deaths by drug or drug class. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed June 3, 2021.

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 163 - 165
PubMed: 35105166

History

Published in print: February 2022
Published online: 2 February 2022

Keywords

  1. Suicide and Self-Harm
  2. Gender Differences
  3. Epidemiology

Authors

Details

Beth Han, M.D., Ph.D., M.P.H.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Md.
Wilson M. Compton, M.D., M.P.E.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Md.
Emily B. Einstein, Ph.D.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Md.
Jessica Cotto, M.P.H.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Md.
Jennifer A. Hobin, Ph.D.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Md.
Jack B. Stein, M.S.W., Ph.D.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Md.
Nora D. Volkow, M.D. [email protected]
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Md.

Notes

Send correspondence to Dr. Volkow ([email protected]).

Funding Information

Dr. Compton reports ownership of stock in General Electric Co., 3M Co., and Pfizer Inc. The other authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share